These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8854134)

  • 21. Growth hormone and insulin-like growth factor-I axis in type 1 diabetes.
    Nambam B; Schatz D
    Growth Horm IGF Res; 2018 Feb; 38():49-52. PubMed ID: 29249623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes.
    Cheetham TD; Holly JM; Clayton K; Cwyfan-Hughes S; Dunger DB
    Diabet Med; 1995 Oct; 12(10):885-92. PubMed ID: 8846679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
    Dunger DB; Acerini CL
    Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group.
    Thrailkill KM; Quattrin T; Baker L; Kuntze JE; Compton PG; Martha PM
    Diabetes Care; 1999 Apr; 22(4):585-92. PubMed ID: 10189536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus.
    Acerini CL; Patton CM; Savage MO; Kernell A; Westphal O; Dunger DB
    Lancet; 1997 Oct; 350(9086):1199-204. PubMed ID: 9652560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic status of children with growth hormone insensitivity syndrome and responses to treatment with IGF-I.
    Brain CE; Hubbard M; Preece MA; Savage MO; Aynsley-Green A
    Horm Res; 1998; 50(2):61-70. PubMed ID: 9701698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of insulin-like growth factor I in normal humans.
    Sherwin RS; Borg WP; Boulware SD
    Horm Res; 1994; 41 Suppl 2():97-101; discussion 102. PubMed ID: 8088711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor I and impaired glucose tolerance.
    Dunger D; Yuen K; Ong K
    Horm Res; 2004; 62 Suppl 1():101-7. PubMed ID: 15761241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S; Bonfanti R; Bitti ML; Germani D; Boemi S; Chiumello G; Boscherini B
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental diabetes mellitus in a teleost fish. II. Roles of insulin, growth hormone (GH), insulin-like growth factor-I, and hepatic GH receptors in diabetic growth inhibition in the goby, Gillichthys mirabilis.
    Kelley KM; Gray ES; Siharath K; Nicoll CS; Bern HA
    Endocrinology; 1993 Jun; 132(6):2696-702. PubMed ID: 8504769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
    Clemmons DR
    Curr Opin Pharmacol; 2006 Dec; 6(6):620-5. PubMed ID: 17030015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
    Tally M; Eriksson U; Thorén M; Brismar K; Hall K
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
    Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
    J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
    Møller N; Orskov H
    Lancet; 1997 Oct; 350(9086):1188-9. PubMed ID: 9652553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.